Prelude Therapeutics (PRLD)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

0.83

3.24%

After-hours Dec 13, 2024, 05:22 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18
Revenue	-	-	-	-	-	-
Cost of Revenue	1.17M	3.04M	2.24M	542.00K	382.00K	149.00K
Gross Profit	-1.17M	-3.04M	-2.24M	-542.00K	-382.00K	-149.00K
Operating Income	-132.28M	-123.54M	-113.73M	-58.76M	-28.11M	-14.97M
Interest Income	-	-	-	-	-	-
Pretax Income	-121.83M	-115.44M	-111.69M	-56.93M	-27.57M	-14.68M
Net Income	-121.83M	-107.34M	-110.78M	-56.93M	-27.57M	-14.68M
Selling & General & Admin	28.88M	30.65M	26.96M	10.59M	3.83M	2.35M
Research & Development	103.39M	92.89M	86.78M	48.18M	24.28M	12.62M
Other Expenses	-	8.10M	2.04M	1.83M	539.00K	295.00K
Operating Expenses	132.28M	123.54M	113.73M	58.76M	28.11M	14.97M
Interest Expense	-	-	-	-	-	-
Selling & Marketing Expenses	-	-	-	-	-	-
Cost & Expenses	132.28M	123.54M	113.73M	58.76M	28.11M	14.97M
Income Tax	-	-8.10M	-915.00K	335.70K	210.14K	295.00K
Shares Outstanding (Basic)	60.36M	47.37M	47.60M	43.71M	32.40M	32.11M
Shares Outstanding (Diluted)	60.36M	47.37M	47.60M	43.71M	32.40M	32.11M
EPS (Basic)	-2.02	-2.27	-2.33	-1.3	-0.85	-0.46
EPS (Diluted)	-2.02	-2.27	-2.33	-1.3	-0.85	-0.46
EBITDA	-131.11M	-122.22M	-112.82M	-58.22M	-27.73M	-14.83M
Depreciation & Amortization	1.17M	3.04M	2.24M	542.00K	382.00K	149.00K